000 01367 a2200361 4500
005 20250514233820.0
264 0 _c20051223
008 200512s 0 0 eng d
022 _a0344-5704
024 7 _a10.1007/s00280-005-0026-3
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDuan, Zhenfeng
245 0 0 _aGBP1 overexpression is associated with a paclitaxel resistance phenotype.
_h[electronic resource]
260 _bCancer chemotherapy and pharmacology
_cJan 2006
300 _a25-33 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650 0 4 _aAntineoplastic Agents, Phytogenic
_xpharmacology
650 0 4 _aCell Line, Tumor
650 0 4 _aDrug Resistance, Neoplasm
_xgenetics
650 0 4 _aGTP-Binding Proteins
_xgenetics
650 0 4 _aGene Expression Profiling
650 0 4 _aGene Expression Regulation, Neoplastic
_xdrug effects
650 0 4 _aHumans
650 0 4 _aOligonucleotide Array Sequence Analysis
650 0 4 _aPaclitaxel
_xpharmacology
650 0 4 _aUp-Regulation
700 1 _aFoster, Rosemary
700 1 _aBrakora, Katherine A
700 1 _aYusuf, Rushdia Z
700 1 _aSeiden, Michael V
773 0 _tCancer chemotherapy and pharmacology
_gvol. 57
_gno. 1
_gp. 25-33
856 4 0 _uhttps://doi.org/10.1007/s00280-005-0026-3
_zAvailable from publisher's website
999 _c15683020
_d15683020